SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011613
Filing Date
2024-03-28
Accepted
2024-03-28 08:01:04
Documents
84
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1407270
2 ex14-1.htm EX-14.1 82175
3 ex19-1.htm EX-19.1 126856
4 ex23-1.htm EX-23.1 4951
5 ex31-1.htm EX-31.1 12937
6 ex31-2.htm EX-31.2 12510
7 ex31-3.htm EX-31.3 12777
8 ex32-1.htm EX-32.1 13382
9 ex97.htm EX-97.1 44443
  Complete submission text file 0001493152-24-011613.txt   6369123

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cocp-20231231.xsd EX-101.SCH 46944
11 XBRL CALCULATION FILE cocp-20231231_cal.xml EX-101.CAL 63190
12 XBRL DEFINITION FILE cocp-20231231_def.xml EX-101.DEF 174526
13 XBRL LABEL FILE cocp-20231231_lab.xml EX-101.LAB 409807
14 XBRL PRESENTATION FILE cocp-20231231_pre.xml EX-101.PRE 325924
88 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 771414
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 24793613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)